Tags |
|
|
Links |
|
|
E-Articles - When Does Being Overweight Turn Into Obesity?
Everybody is familiar with the term overweight and most of us will have experienced being overweight. Indeed, many of us will be more or less
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
permanently overweight and simply live with it. But what is the difference between being overweight and being clinically obese?
Well the si
Well the si
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
mple answer would be to say that being obese is nothing more than being very overweight. In other words, it's simply a matter of degree. Unfo
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
rtunately, this answer misses the central issue of obesity.
Putting on a few pounds won't do you any real harm and, apart from the fact that
Putting on a few pounds won't do you any real harm and, apart from the fact that
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
your pants may feel a little tight and you may be less than happy with the way you look, there are even some people who believe that carryin
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
a little extra weight might actually be good for you. Indeed, there are some studies that show that death rates are slightly lower amongst i
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
ndividuals who are slightly overweight, although there is considerable debate about whether or not this is actually related to weight or resu
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
lts from other factors which are more often seen in people who are overweight.
Once your weight passes a certain level though, so that you a
Once your weight passes a certain level though, so that you a
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
re now carrying sufficient extra weight to be classed as being obese, the scales tip and you begin to run the risk of developing a series of
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
health problems as a result of your excess weight. Indeed, if your weight continues to climb, these health problems can literally become life
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
threatening and your obesity will then be classed as morbid obesity.
This is all very well, but how do you know whether you're simply overwe
This is all very well, but how do you know whether you're simply overwe
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
ight or obese?
The main measure of obesity was developed by a Belgian statistician and anthropometrist named Adolphe Quetelet nearly one hun
The main measure of obesity was developed by a Belgian statistician and anthropometrist named Adolphe Quetelet nearly one hun
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
dred and fifty years ago and is referred to as the measurement of body mass index, or BMI. In simple terms your BMI is calculated by dividing
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
your weight in kilograms by the square of your height in metres. So, if you are 1.7 metres tall and weigh 70 kilograms your BMI would be 24.
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
2 [70 ? (1.7x1.7)].
A BMI of between 18.5 and 24.9 is considered to be normal. Between 25.0 and 29.9 you would be classed as being overweigh
A BMI of between 18.5 and 24.9 is considered to be normal. Between 25.0 and 29.9 you would be classed as being overweigh
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
. Once you reach a BMI of 30 you are considered to be obese and, if your BMI reaches or exceeds 40 you are morbidly obese.
BMI is designed a
BMI is designed a
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
s a general guide but there are circumstances in which it is possible to have a BMI of less than 30 and still be clinically obese and indeed
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
to have a BMI of more than 30 and not to be classed as being obese. A lean but muscular individual could, for example, have a BMI of over 30
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
but, in this case, the excess weight would be provided by muscle rather than by fat.
As a result, where your weigh becomes a concern and obe
As a result, where your weigh becomes a concern and obe
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
sity a possible issue, further more accurate tests should be carried out by your doctor to determine whether or not your are clinically obese
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.e-article.org.ua/article/261431/e-article-When-Does-Being-Overweight-Turn-Into-Obesity.html">When Does Being Overweight Turn Into Obesity?</a>
BB link (for phorums):
[url=http://www.e-article.org.ua/article/261431/e-article-When-Does-Being-Overweight-Turn-Into-Obesity.html]When Does Being Overweight Turn Into Obesity?[/url]
Related Articles:
Are Management Roles Changing Today?
Ensure your Financial Progress with Unsecured Debt Consolidation Loan
There is an Article Deep Down Inside of You Just Looking to Bust Out
Bookmark it:
|